Skip to main content
. 2020 Nov 10;5(46):30274–30281. doi: 10.1021/acsomega.0c04795

Figure 4.

Figure 4

Effect of various formulations on the MCF-7/ADR cell apoptosis. (A) Percentage of the MCF-7/ADR cells in apoptosis after treatment with MS SLNs (25, 50, and 100 μM), Qu (25, 50, and 100 μM), or Qu-SS-Gcc LNPs (25, 50, and 100 μM) for 24 h, as detected by flow cytometry. (B) Immunoblot analysis of apoptosis-related proteins. Caspase-3 and caspase-9 are shown after the Qu (50 μM) or Qu-SS-Gcc LNP (50 μM) treatment, as detected by western blots.